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Directed differentiationHuman embryonic stem cells (hESC) are capable to give rise to all cell types in the human body during the
normal course of development. Therefore, these cells hold a great promise in regenerative cell replacement
based therapeutical approaches. However, some controversy exists in literature concerning the ultimate fate
of hESC after exposure to genotoxic agents, in particular, regarding the effect of DNA damaging insults on
pluripotency of hESC. To comprehensively address this issue, we performed an analysis of the expression of
marker genes, associated with pluripotent state of hESC, such as Oct-4, Nanog, Sox-2, SSEA-4, TERT, TRA-1-60
and TRA-1-81 up to 65 h after exposure to ionizing radiation (IR) using ﬂow cytometry, immunocytochem-
istry and quantitative real-time polymerase chain reaction techniques. We show that irradiation with
relatively low doses of gamma-radiation (0.2 Gy and 1 Gy) does not lead to loss of expression of the
pluripotency-associated markers in the surviving hESC. While changes in the levels of expression of some of
the pluripotency markers were observed at different time points after IR exposure, these alterations were not
persistent, and, in most cases, the expression of the pluripotency-associated markers remained signiﬁcantly
higher than that observed in fully differentiated human ﬁbroblasts, and in hESCs differentiated into deﬁnitive
endodermal lineage. Our data suggest that exposure of hESC to relatively low doses of IR as a model
genotoxic agent does not signiﬁcantly affect pluripotency of the surviving fraction of hESC.ES cells, embryonic stem cells;
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Human embryonic stem cells (hESCs) possess the capacity to
differentiate into all cell types in the body (pluripotency) and, as such,
can serve as a valuable model of embryonic development. Human
ESCs are an ultimate source of differentiated cells that may be used in
cell-based substitutive therapy (Liew et al., 2005). To fully beneﬁt
from the regenerative potential of hESCs in clinical settings one has to
anticipate problems inherent to the unique biological characteristics
of ES cells. The key properties of ES cells under normal conditions are
their ability to self-renew and to maintain pluripotency. However,
published data concerning the ultimate fate of ES cells after exposure
to genotoxic stress are somewhat contradictory. On the one hand,both murine, non-human primate and human ES cells were shown to
be hypersensitive to DNA damaging agents and respond by undergo-
ing apoptosis and/or differentiation (Aladjem et al., 1998; Hong and
Stambrook, 2004; Lin et al., 2005; Qin et al., 2007). It is also known
that the developing human embryo is considered to be among the
most vulnerable to genotoxic agent exposures (McCollough et al.,
2007). On the other hand, a more recent study suggests that hESC
maintain pluripotency for at least 24 h after 2 Gy of IR exposure
(Momcilovic et al., 2009). Hence, how DNA damaging agents, for
instance, IR exposure with relatively low doses, might affect the
pluripotency state of hESCs remains to be addressed.
The key regulators of pluripotency are transcription factors Oct-4,
Nanog and Sox-2; they are found to be expressed in undifferentiated
stem cells (Matin et al., 2004; Boyer et al., 2005; Hyslop et al., 2005).
Together with these factors comprising the core of the transcription
regulatory circuitry underlying undifferentiated state of stem cells,
hESCs can be characterized by the expression of SSEA-4, TRA-1-60,
TRA-1-81 and TERT (Ginis et al., 2004; Fong et al., 2009). In order to
shed light on how genotoxic stress such as IR affects the pluripotent
state of hESC in culture, in this study we comprehensively character-
ized the expression of these markers after IR exposures of hESC using
three independent methodologies. In addition, in this study we
cultivated hESC using feeder free conditions to avoid potential effects
of MEFs on the measurements of expression of pluripotency markers.
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2.1. Cell lines and cell culture
Initially hESCs (H9 cell line, WiCell, Madison, WI, passage 35–40)
were maintained on a feeder layer of irradiated MEFs using medium
consisting of 80% Knockout Dulbecco's modiﬁed Eagle's medium (KO-
DMEM, Invitrogen, Carlsbad, CA) supplemented with 15% Fetal bovine
serum (Invitrogen), 5% Knockout serum replacement (KSR, Invitro-
gen), 0.1 mM 2-mercaptoethanol (Sigma, St. Louis, MO), 1% non-
essential amino acids, 2 mM L-Alanyl-L-glutamine and 4 ng/ml basic
ﬁbroblast growth factor (bFGF, Invitrogen). Cell cultures were
passaged using Collagenase IV (Invitrogen) every 6–7 days, only
phenotypically uniform hESC colonies were collected. Subsequently,
hESCs were transferred to feeder-independent culture conditions,
using BD Matrigel hESC-qualiﬁed Matrix (BD Biosciences, San Jose,
CA), and grown in mTeSR-1 (Stemcell Technologies, Vancouver,
Canada) at 37 °C and 5% CO2. Cell cultures were maintained and ex-
panded following the manufacturer's protocol. The medium was
changed every day.
BJ and IMR-90 normal human diploid ﬁbroblasts (ATCC, Manassas,
VA) were grown in Earle's modiﬁed Eagle's medium (EMEM)
supplemented with 10% fetal bovine serum, non-essential amino
acids, 1 mM sodium pyruvate and 2 mM L-glutamine (Invitrogen) at
37 °C and 5% CO2 and passaged every 5–7 days using 0.5% Trypsin-
EDTA.
Exposure of cells to ionizing radiation was accomplished as
follows: cultured cells were divided into three groups and were
exposed either to 0.2 Gy or 1 Gy of 60Co gamma-radiation using
Eldorado 8 60Co teletherapy unit (MDS Nordion, Ottawa, Ontario,
Canada, formerly Atomic Energy of Canada, Ltd.; dose rate about 1 Gy/
min), or, alternatively, were sham-irradiated. Cells then were
returned to CO2 incubator and collected at 17 h, 41 h and 65 h post-
irradiation for analysis. These time points correspond to approxi-
mately 1, 2 and 3 average duplication time for H9 hESC line (Becker
et al., 2006).
2.2. Directed differentiation of hESC into deﬁnitive endoderm
H9 hESCs were seeded onto 6-well plates covered with BD
Matrigel hESC-qualiﬁed Matrix (BD Biosciences) at 105 cells per
well. Then, the cells were maintained in mTeSR1 medium at 5% CO2
and 37 °C for two days with the medium changed every day. Starting
from day three cells in culture were maintained in differentiation
medium (DMEM/F12 supplementedwith 20% KSR, 100 ng/ml Activin
A, 4 ng/ml bFGF and 20 µM LY294002), which was changed every day
(McLean et al., 2007). After four days of differentiation cells were
trypsinized and collected for further studies.
2.3. Immunocytochemistry
For immunohistochemistry cells were grown on glass-bottom
LabTek® two-well Chamber Slide™ (BD Biosciences) in the feeder-
free conditions described above. The cell cultures were ﬁxed with 4%
paraformaldehyde for 10 min, and then permeabilized with 0.1%
Triton-X-100 in phosphate-buffered saline (PBS) for 5 min. Primary
antibodies were applied for 1–2 h (overnight at 4 °C for cleaved
caspase 3), and appropriately coupled Alexa Fluor secondary anti-
bodies (Invitrogen) were used for single or double labeling for 1 h. All
secondary antibodies were tested for nonspeciﬁc immunoreactivity.
The following primary antibodies were used: Oct-4, SSEA4, TRA-1-81,
Nestin, and Sox7 (Santa Cruz Biotechnology, Santa Cruz, CA), cleaved
caspase 3 (Cell Signaling Technology, Danvers, MA), TERT and
Brachyury (Abcam, Cambridge, MA). DAPI stain was used to identify
the nuclei. After mounting in antifade media (VectaShield, Vector
Laboratories, Inc., Burlingame, CA), the samples were examined byAxioplan Zeiss epiﬂuorescent microscope (Carl Zeiss, Thornwood,
NY). The camera exposure time and microscope settings were kept
constant across all corresponding samples.
2.4. Cell viability and ﬂow cytometry
At the indicated time points, ﬂasks containing hESCs were rinsed
with PBS supplemented with 0.5% bovine serum albumin (BSA,
Sigma) to remove detached cells. Then the remaining cells, that we
call surviving fraction, were collected by treatment with Trypsin-
EDTA for 3 min at 37 °C, and washed three times with PBS buffer
supplemented with 0.5% BSA. Before the third wash cell pellet was
resuspended in 1 ml of the same buffer, and 50 µl aliquot was taken
into Trypan Blue exclusion assay. Cell count was performed using
hemacytometer for each aliquot immediately after addition of equal
volume of Trypan Blue.
To assess the viability of hESC in colonies after IR exposures, cells
were incubated at 37 °C for 1 h with Hoechst 33342 (8 μg/ml;
Molecular Probes, Eugene, OR) and propidium iodide (PI, 20 μg/ml;
Sigma, St. Louis, MO). Hoechst 33342 is known to stain the nuclei of
both live and dying cells whereas PI penetrates the cell membrane of
only dying/dead cells. Cell colonies were visualized using an inverted
ﬂuorescence microscope (Axiovert 200 M, Thornwood, NY) equipped
with a ﬂuorescent light source.
For ﬂow cytometry experiments, each sample was diluted with
PBS/0.5% BSA buffer yielding a total of 3×105 cells. For analysis of the
expression level of cell surface antigens, cells were incubated either
with SSEA-4-phycoerithrin (PE)-conjugated antibody (R&D Systems,
Minneapolis, MN), or with TRA-1-60 antibody (Santa Cruz Biotech-
nology) and, after two washes with PBS/0.5% BSA buffer, with
secondary FITC-conjugated antibody (Vector Laboratories, Inc.). Prior
to staining, cells were blocked with human IgG for 15 min at room
temperature. For intracellular staining with Oct-4-PE and Sox2-PE
conjugated antibody (R&D Systems), the cells were ﬁxed with 4%
paraformaldehyde in PBS for 10 min, washed two times with PBS and
permeabilized with 0.1% saponin (Sigma) in PBS prior to incubation
with antibodies. All antibody incubations were performed according
to the manufacturer's instructions. Isotype controls were included for
each antibody staining.
After staining, cells were washed and resuspended in PBS.
Fluorescence activated cell sorting (FACS) analysis was performed
on a FACSCalibur (Becton Dickinson Immunocytometry Systems, San
Jose, CA) utilizing an emission wavelength of 488 nm and a 525 nm
excitation detector. Cell Quest Pro software was used for both data
acquisition and analysis to produce histogram plots and median peak
values. As a control for nonspeciﬁc binding for each conjugated
antibody we used the same IgG subclass with the same ﬂuorochrome
conjugation and for non-conjugated antibody— the same IgG subclass
conjugated to ﬂuorochrome. A total of 10,000 events were acquired
for each analysis.
2.5. Quantitative RT-PCR
Cells were trypsinized, washed two times with PBS and ﬁnally
suspended in PBSwith a concentration of 10,000 cells per µl. cDNAwas
synthesized using SuperScript III CellsDirect cDNA System (Invitro-
gen) according to the manufacturer's recommendations. Quantitative
real-time PCR (qPCR) was performed on iCycler iQ instrument (Bio-
Rad, Hercules, CA) using SYBR GreenER qPCR SuperMix for iCycler
(Invitrogen). Primers were purchased from Qiagen (Quantitech
Primer Assays, Valencia, CA). PCR protocol consisted of 50 °C for
2 min, 95 °C for 10 min, followed by 50 cycles (95 °C — 15 s, 55 °C —
30 s, 72 °C — 30 s) according to Quantitech Primer Assay recommen-
dations. Ct (cycle threshold) values were obtained for each sample,
averaged over triplicates in two biological replicates andnormalized to
beta-actin, according to the formula E=2(Ct[beta-actin]−Ct[studied gene]),
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and Ct[studied gene] are Ct values of beta-actin and studied gene in
corresponding samples. Data are presented as mean plus/minus
standard error. Differences were considered statistically signiﬁcant at
p value less than 0.05.
3. Results
3.1. Analysis of cell viability
To examine the viability of hESC in culture after IR exposure, we
stained the cells with vital dye assessing the percentage of cells in a
population that excludes the dye indicative of cell survival. Only the
colony-forming cells that remained attached were counted in this
assay. The results of this count are shown in Table 1. The total number
of the attached cells decreases at all time points roughly proportional
to the received dose of IR. This decrease was most likely due to
apoptosis that was observed at the early time points after irradiation
by staining cell colonies with cleaved caspase 3 antibody, an early
marker for apoptosis (Fig. 1A and B). We followed the irradiated cells
for up to 65 h that correspond to approximately four cycles of cell
division; after that sham-irradiated control cells became overgrown
and thus required to be split. The sham-irradiated cells demonstrated
viability in the range 87%–94% up to 65 h of post-exposure incubation.
The percentage of viable cells among the attached hESCs did not
change after exposure to both doses of IR with exception of 65 h post
1 Gy irradiation when viability dropped to 72.1%. The surviving cells
formed colonies characteristic of normal hESCs (Fig. 1D). Staining
with Hoechst 33342 and propidium iodide revealed that cells
permeable to the latter die that are presumably dead were localized
mostly at the periphery of the colonies or were detached (Fig. 1C)
Therefore, we conclude that despite dose-dependent cell death the
majority of the remaining colony-forming attached hESCs that we
used in our subsequent assays were viable, at least in terms of
integrity of their cytoplasmic membrane.
3.2. Immunocytochemical analysis of pluripotency and early
differentiation markers
To qualitatively assess the expression and intracellular distribution
of established markers of pluripotency, we performed an immunocy-
tochemical analysis of cultured H9 cells following irradiation with
0.2 Gy and 1 Gy doses up to 65 h post-IR (Fig. 2). There was no
detectable expression of Oct-4, SSEA-4, TERT, TRA-1-81 in primary
human BJ ﬁbroblasts (data not shown). However, in H9 cells Oct-4
showed an intranuclear pattern of staining, TERT (catalytic subunit of
telomerase) demonstrated intracellular localization and SSEA-4
localized to cell surface. Compared to sham-irradiated controls
(Fig. 2A), neither 0.2 Gy nor 1 Gy irradiation led to any noticeable
changes in expression and/or intracellular distribution of these
markers of pluripotency (Fig. 2B and C). To further characterize the
response of H9 hESCs to IR, we examined the expression of markers of
early differentiation, such as, Nestin (ectodermal lineage), Brachyury
(indicative of mesoendoderm differentiation) and Sox7 (endoderm)
after IR exposure. We found no up-regulation of these gene productsTable 1
H9 hESC post-IR cell count and viability.













17 h 94 122×104 89.7 78×104 87.1 31×104
41 h 86 144×104 93.1 116×104 95.2 21×104
65 h 87 336×104 89.3 225×104 72.1 44×104up to 65 h post-IR, suggesting the continued undifferentiated state of
cells, as judged by immunocytochemistry.
3.3. Analysis of pluripotency markers with ﬂow cytometry
We used ﬂow cytometry to quantitatively follow the expression
level of both intracellular and cell surface antigens known to be
associated with pluripotent state of stem cells. Histogram plots
derived from ﬂow cytometry experiments using cells stained with
indicated antibodies are shown in Fig. 3, while themedian peak values
obtained from these histograms are presented in Table 2. For Oct-4,
we observed a slight increase in the expression level of this
transcription factor after exposure of hESCs to 0.2 Gy at 17 h post-
IR. After 41 h a slight increase in Oct-4 expression was observed only
in 1 Gy irradiated sample, while the expression of Oct-4 in 0.2 Gy
irradiated sample was even slightly lower than that in the sham
control. After 65 h post-IR expression of Oct-4 remained somewhat
elevated for both 0.2 Gy and 1 Gy samples (Fig. 3, top row). The
expression of Sox-2, which is another transcription factor essential for
maintenance of pluripotency in stem cells, was not changed at 17 and
41 h, however a slight increase was observed at 65 h after IR exposure
(Fig. 3, second row). The expression of cell surface glycosphingolipid
antigens associated with pluripotency in stem cells revealed a more
complicated pattern after IR exposure. Expression of cell surface
glycosphingolipid SSEA-4 after 0.2 Gy irradiation of H9 cells was not
signiﬁcantly changed up to 65 h compared to sham-irradiated control
cells (Fig. 3, third row). In contrast, exposure of hESCs to 1 Gy dose of
IR led to a 2.4-fold decrease in the expression level of SSEA-4 at 17 h
post-IR, followed by a transient increase at 41 h time point and
returned to a lower level than in sham-irradiated cells by 65 h post-IR.
We investigated the pattern of expression of yet another cell surface
hESC pluripotency marker, namely TRA-1-60 (Fig. 3, bottom row). In
general, expression of this marker varied signiﬁcantly within hESC
population. We observed a 1.5–1.6 fold increase following 0.2 Gy and
1 Gy IR exposures only at the earliest post-IR time point studied
(17 h). Later, expression of TRA-1-60 returned to the level close to
that of sham-irradiated hESCs.
3.4. Analysis of expression of pluripotency markers with qRT-PCR
To further validate our ﬁndings, we quantitatively assessed the
changes in gene expression for established markers of pluripotency
state in hESCs with qRT-PCR experiments (Fig. 4). For two genes, Oct-
4 and Nanog, which constitute the core of transcriptional machinery
governing the pluripotency of hESCs, no statistically signiﬁcant
changes were observed for sham-irradiated H9 cells over the entire
course of our studies; the slight increase in both Oct-4 and Nanog
expression at 41 h after irradiationwas not statistically signiﬁcant and
apparently consistent with natural variation in the expression level of
these genes in H9 cells in culture. In contrast, after irradiation of hESCs
with 1.0 Gy expression of both Oct-4 and Nanog became somewhat
increased at 17 h, and then went down at 41 h post-irradiation after
both doses of IR. However, at 65 h after irradiation expression of both
markers returned to the level (Oct-4, 0.2 Gy) or even remained
elevated compared to the level of expression in the sham irradiated
control. To further validate the results of qRT-PCR assay, we set up two
independent control experiments. First, as a negative control, we
examined the level of expression of Oct-4 and Nanog genes in IMR-90
human primary diploid ﬁbroblasts representing differentiated cells of
the human fetal lung. Second, we employed a scheme of directed
differentiation of pluripotent H9 cells into deﬁnitive endoderm. In the
case of IMR-90 cells, the levels of expression of Oct-4 and Nanog genes
were undetectable with our assay. In the case of the cells dif-
ferentiated into endoderm the level of expression of Oct-4 was
considerably lower while the level of expression of Nanog was
comparable with that of non-differentiated cultured H9 cells (Fig. 4).
Fig. 1. Apoptosis induction assay. The cells were grown as described inMaterials andmethods section, then either irradiated with 1 Gy IR or sham-irradiated and allowed to incubate
for either 6 h before staining with cleaved caspase 3 antibody (Casp3) (A,B), or for 65 h before staining with Hoechst 33342 and propidium iodide (PI) (C,D). A,B: merged images of a
hESC colony are shown (blue — DAPI, red — cleaved caspase 3), magniﬁcation 40×. C,D: C — merged image of hESC colonies is shown (blue — Hoechst 33342, red — propidium
iodide); D — bright ﬁeld image of the same colony, magniﬁcation 5×.
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IR exposures with 0.2 Gy and 1.0 Gy led to an increase in
expression of apoptotic marker and a decrease in cell count that
was roughly proportional to the received radiation dose within hESCs
colonies. After detachment and removal of the apoptotic cells, the
surviving fraction of the hESCs formed characteristic colonies and
remained viable in terms of maintaining integrity of their plasma
membrane. These observations are in agreement with published
reports where other authors demonstrated massive apoptosis in
hESCs irradiated IR with doses of equal or more than 2 Gy or with UV
light (Qin et al., 2007; Filion et al., 2009; Momcilovic et al., 2009).
However, in the above studies hESCs were exposed to considerably
higher doses of gamma (2 Gy and 5 Gy), or a lethal dose of UV
irradiation; and the analyses of cell responses were carried out within
24 h post irradiation on the mixture of dying and/or dead and
surviving cells. To the best of our knowledge, no studies of hESCs
responses to IR following exposures with relatively low doses (below
1 Gy) have been reported in the literature. Low-dose irradiation is
more relevant in research and/or clinical settings where computer
tomography (CT), positron emission tomography (PET), single photon
emission computer tomography (SPECT) and other IR imaging
techniques may be used to assess the success of human stem cell
based substitutive therapy. The ﬁndings in our study suggest that low-
dose IR exposures may not adversely affect the potential of hESC to
survive and retain pluripotency.
It is generally appreciated that transcriptional control contributes
to the maintenance of pluripotency, and three transcription factors,
including the homeodomain proteins Oct-4 and Nanog, and the SRY-
related HMG box containing protein Sox-2, have been involved in the
maintenance of pluripotent hESCs (Matin et al., 2004; Boyer et al.,
2005; Hyslop et al., 2005; Chambers and Tomlinson, 2009). Interest-
ingly, it has been shown that Oct-4 must be present at appropriate
levels to maintain pluripotency, because even a twofold increase inexpression causes differentiation into primitive endoderm and
mesoderm, whereas loss of Oct-4 induces the formation of trophec-
toderm accompanied by a loss of pluripotency (Niwa et al., 2000). In
our experiments, the levels of Oct-4 mRNA expression were on level
or slightly elevated at 17 and 65 h post-IR and signiﬁcantly lower at
41 h as compared with sham-irradiated controls (Fig. 4). However,
this variation in the mRNA levels did not translate to sizeable changes
in the expression of Oct-4 protein (Fig. 3) suggesting that the cell
cultures retained the undifferentiated state associated with the Oct-4
expression.
Expression of the homeodomain protein Nanog has been shown to
be absent from differentiated cells (Chambers et al., 2003). Nanog is
considered not only to maintain pluripotency, but also to inhibit the
transition of undifferentiated hES cells to primitive endoderm (Zhou
et al., 2007). Our data indicate that the expression level of Nanog
mRNA after some decrease at 41 h remained elevated at 65 h post-IR
following irradiation with both 0.2 Gy and 1 Gy dose as compared
with that in sham-irradiated controls. It is worth mentioning here
that, as it was observed before (Momcilovic et al., 2009), a decrease in
mRNA levels of Oct-4 and Nanog did not translate to immediate
changes in protein levels of these transcription factors.
It has been shown that downregulation/knockdown of Sox-2 is
associated with differentiation/trophectoderm development in
human ESCs (Fong et al., 2008). Our ﬁndings show that the expression
of Sox-2 remains at approximately the same level after both mock-
and IR exposures up to 65 h post-IR. These three transcription factors
have been demonstrated to co-occupy a signiﬁcant portion of target
genes (Boyer et al., 2005; Kim et al., 2008). In human hESCs, the
network governed by Oct-4, Nanog and Sox-2 activates or suppresses
gene transcription, including many key genes that are transcriptional
regulators involved in lineage speciﬁcation during development
(Boyer et al., 2005; Kim et al., 2008).
The cell surface glycosphingolipids SSEA-4, TRA-1-60 and TRA-1-81
have been shown to be present on hESCs and human embryonic
Fig. 2. Immunocytochemical analyses of IR exposure effects on pluripotency in cultured H9 hESC. A. Mock-irradiation, 65 h. B. Irradiation with 0.2 Gy dose, 65 h post-IR. C. Irradiation
with 1 Gy dose, 65 h post-IR. Shown are representative images depicting the expression patterns of corresponding proteins described in theMaterial andmethods, bar code equals to
10 μm.
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ation (Thomson et al., 1998; Reubinoff et al., 2000).We showedmodest
up-regulation after 0.2 Gy and down-regulation after 1 Gy IR of SSEA-4
andessentiallynochanges in expressionof TRA-1-81 (Fig. 2) andTRA-1-
60 (Fig. 3) at the latest timepoint studied (65 h) following IR exposures,
implying that H9 hESCs retain high level of expression of thesemarkers
following IR. It is noteworthy that contradictory data are available forSSEA-4 in the literature; some showing SSEA-4 to be non-essential for
hESCs pluripotency (Brimble et al., 2007). Therefore, the biological
importance of down-regulation of SSEA-4 observed in our studies at
17 h following 1 Gy IR exposures of hESCs is unclear. Based on the
totality of the obtained data we conclude that pluripotency of surviving
hESCs is not considerably affected by IR exposures up to 1 Gy dose at
least until 65 h post-irradiation.
Fig. 3.Histograms showing expression of markers of pluripotency following IR exposures of cultured H9 hESC determined in ﬂow cytometry experiments (0 Gy— red, 0.2 Gy— blue,
1 Gy — yellow).
13M.V. Sokolov et al. / Gene 455 (2010) 8–15Activation of p53 involved a substantial reduction in expression of
bothNanog (on the second day after treatment) and Oct-4 (on the third
day) concomitant with the increase in expression of markers of early
differentiation (Maimets et al., 2008). It has been established thatTable 2
Expression of pluripotency markers from ﬂow cytometry experiments. Numbers
represent median peak values derived from histograms shown in Fig. 3.
17 h post IR 41 h post IR 65 h post IR
0 Gy 0.2 Gy 1 Gy 0 Gy 0.2 Gy 1 Gy 0 Gy 0.2 Gy 1 Gy
Oct-4 18.9 28.6 22.3 8.4 6.2 10.2 7.6 10.8 9.2
Sox2 11.9 11.4 11.1 6.7 6.5 7.2 3.5 4.7 4.6
SSEA4 858 882 359 711 757 922 334 441 183
TRA-1-60 17.3 27.4 25.3 14.1 15.1 12.6 17.6 17.3 19.3murine as well as human ES cells reduces the expression of Nanog and
undergoes differentiation in response to DNA damage (Lin et al., 2005;
Qin et al., 2007). Previous studies showed that themRNA levels forOct-4
and Nanog decreased relative to non-irradiated cells 6 h following 2 Gy
irradiation (Filion et al., 2009) consistent to what has been demon-
strated in murine and human ES cells (Lin et al., 2005; Qin et al., 2007).
Interestingly, mRNA levels returned to those observed in sham-
irradiated cells by 24 h post 2 Gy exposure and there was no decrease
in the protein level of Oct-4 andNanog over the 24 h period following IR
exposure, suggesting that human ES cells remained pluripotent
(Momcilovic et al., 2009). This observation is in agreement with our
ﬁndings which we report in this study. However, we extended this
observation and present the results here that hESCs retain the
expression of pluripotency markers at least up to 65 h post 0.2 Gy or
1 Gy IR exposures. To the best of our knowledge, no previous reports
were published examining the pluripotency of hESCs following
Fig. 4. Expression of pluripotency markers mRNA following IR exposures of cultured H9
hESC (0 Gy — red, 0.2 Gy — blue, 1 Gy — yellow) measured by qRT-PCR. Expression
levels are relative to the expression of beta-actin calculated as described in Materials
and methods. Statistically signiﬁcant differences in the expression levels of irradiated
samples versus unirradiated controls are marked with stars. Differences were
considered statistically signiﬁcant at p value less than 0.05.
14 M.V. Sokolov et al. / Gene 455 (2010) 8–15relatively low, clinically relevant doses of IR up to a timepoint
corresponding to about four population doublings in hESCs (Becker
et al., 2006).
It has been shown recently that hESC in culture may undergo
transient cell cycle arrest following IRexposure (Momcilovic et al., 2009).
Interestingly, Oct-4 has been reported to sustain proliferation of ESC by
repressing p21, and, as such, be involved in cell cycle control of ESC (Lee
et al., 2010). However, markers of pluripotency (Oct-4, Nanog, tumor
rejectionantigens etc.) arenot knowntobeexpressedonly at speciﬁc cell
cycle stages in hESC; therefore the relevance of cell cycle arrest on
maintenance of pluripotency of hESC after IR is not directly evident.
One of the intriguing aspects of our results pertains to an apparent
temporal change/ﬂuctuation of the pluripotency marker expression
levels at early time-points following IR exposures. This phenomenon
has been previously observed (Momcilovic et al., 2009). It could be
explained by the fact that epigenetics of pluripotent hESCs is distinct
from that of somatic cells. It has been shown that the chromatin in
ESCs exists in amuchmore open, “breathable” state in contrast to fully
differentiated somatic cells (Meshorer et al., 2006); and promoters of
many genes, including developmentally important genes, bear
“bivalent marks” such as activating marks for transcription associated
with methylation of histone3, lysine 4 (H3K4) and, at the same time,
repression marks connected with methylation of histone3, lysine 27
(H3K27) (Bernstein et al., 2006). As such, the expression of genes can
be modulated and ﬁne-tuned very quickly in response to internal/
external cues, such as IR. Alternatively it is possible that temporal
changes/ﬂuctuation of the pluripotency marker expression levels
observed in our studies at early time points following IR exposures
reﬂect the stochastic noise/heterogeneity inherent to hESCs cultures
(Hough et al., 2009) and exacerbated by inﬂuence of genotoxic agent.
This may also explain the temporal differences in the shapes of curvesdepicting the distribution pattern for the expression of pluripotency
markers on our ﬂow cytometry data graphs (Fig. 3).
5. Conclusions
We believe our report is the ﬁrst study to systematically examine
the inﬂuence of IR exposure on pluripotency in hESCs. We found that
the pluripotency of surviving hESCs, judged by the markers of
undifferentiated state, is not affected by IR exposures in doses up to
1 Gy. These ﬁndings could provide an important foundation for the
design and implementation of stem cell monitoring techniques in
research settings. Our experimental data could perhaps also help to
overcome one of the key uncertainties for clinical testing in patients
participating in the translation of hESC based therapy from experi-
ment to clinical practice.
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